In this episode, host Tylah Tully unpacks the latest news from Neurizon Therapeutics (ASX:NUZ), who has securing a new ...

Has China's flex in iron ore negotiations laid the groundwork for a BHP-Rio Tinto merger? RBC's Kaan Peker seems to think so.

Australia globally recognised for world-class life sciences but needs more funding from investors to support companies at ...

The ASX climbed as Albo’s White House handshake with Trump lit up the miners, gold broke records, and heavyweights like BHP ...

Island Pharma aims to turn Galidesivir, its antiviral ace against Marburg, into reality – with the FDA’s November call to ...

Host Tylah Tully looks at gold explorer Astral Resources (ASX:AAR) in the latest episode of Who’s Who on the ASX.

Activity has ramped up again at an emerging gold field east of Kalgoorlie, as Riversgold (ASX:RGL) begins grade-control ...

Anson Resources (ASX:ASN) is mobilising a drill rig to re-enter a key well in a move to unlock more lithium at Green River.

Neurotech (ASX:NTI) is a clinical-stage biopharmaceutical company developing cannabinoid therapies for paediatric ...

With global attention on REEs reaching a fever pitch, VTM (ASX:VTM) has materially increased the grades of three important heavy rare earths.

A trifecta of gains for junior critical minerals players on the eve of talks in the US between Prime Minister Albanese and ...

The ASX 200 has risen against a falling gold price, with blue chip stocks fuelling a 0.41pc gain for the market in Monday ...